OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial

By afschroeder • March 20, 2026

Alhelaly M, Soylu C, Oncel D, Corradetti G, Chen K, Jackson NJ, Rathinam SR, Gonzales JA, Thundikandy R, Kanakath AV, Murugan SB, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Sadda SR, Madow B, Coyne AB, Acharya NR, Tsui E. OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial. Ophthalmol Sci. 2026 Feb 5;6(4):101106. doi: 10.1016/j.xops.2026.101106. PMID: 41853570; PMCID: PMC12995472.

Tags: DOM STAT, FAST, General Internal Medicine, OCT-based vitreous signal intensity, Publications, Standardization of Uveitis nomenclature, uveitis, Vitreous haze

Correction: A workshop considering genetic research and data collection with American Indian and Alaska Native people outside of tribal jurisdiction

Beans JA, Blanchard J, Hiratsuka V, Helton T, Carroll S, Dillard D, Orr R, Gachupin FC, Hull S, Haring RC, Garrison NA, Saukeah B, Tsosie[...]

Psychological factors as mediators of the effectiveness of telehealth mindfulness-based interventions for pain and pain-related conditions

Taylor SL, Calvert C, Haley AC, Evans R, Adamowicz J, Allen KD, Bronfort G, Cross LJS, Goldsmith ES, Grant A, Leininger B, Matthias MS, Serpa[...]

Maintaining control: challenges and facilitators to medication adherence among young adults with HIV and recent criminal legal system experience or high risk for system involvement

Mungo L, Harawa NT, Seiden D, McAvoy-Banerjea J, Wang L, Brewer RA, Belzer M. Maintaining control: challenges and facilitators to medication adherence among young adults[...]